Nephros (NEPH) Non Operating Interest Expenses (2011 - 2026)

Nephros has reported Non Operating Interest Expenses for 15 years, with the latest figure at $29000.0 in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 17.14% year-over-year to $29000.0 in Q2 2026; TTM through Jun 2026 was $124000.0, a 12.68% decrease from a year earlier, with the FY2025 full-year figure at $140000.0, up 3.7% from the prior year.
• Non Operating Interest Expenses was $29000.0 for Q2 2026 at Nephros, roughly flat from $29000.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $213000.0 in Q4 2023, with the low at $1000.0 in Q1 2023.
• Average Non Operating Interest Expenses over 5 years is $35562.5, with a median of $32500.0 recorded in 2024.
• The largest YoY upside for Non Operating Interest Expenses was 7000.0% in 2023 against a maximum downside of 88.89% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $3000.0 in 2022, then jumped by 7000.0% to $213000.0 in 2023, then slumped by 84.04% to $34000.0 in 2024, then declined by 5.88% to $32000.0 in 2025, then declined by 9.38% to $29000.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $29000.0 (Q2 2026), $29000.0 (Q1 2026), and $32000.0 (Q4 2025), per Business Quant data.